Pharma Business International | The voice of the Pharma industry

R&D

Orion and Abilita Therapeutics to develop innovative antibody therapeutics

20th December 2024

Orion Corporation and Abilita Therapeutics have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas of oncology and pain. Under the...

APPROVALS

Roche’s Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness

R&D

Conduit Pharmaceuticals partners with Sarborg to leverage AI and cybernetics to optimize drug development

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Amazon Filters launches high-temp vent filter for pharma and biotech

A UK process filter manufacturer has launched an enhanced high-temperature-resistant membrane product aimed at vent applications across the global pharmaceutical and biotechnology markets. Amazon Filters’...

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Beckman Coulter and Scopio Labs add world’s first digital bone marrow imaging and analysis to long-term partnership

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Er-Kim extends exclusive distribution agreement with Ascendis to expand commercialization of endocrinology portfolio

Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma to commercialize...

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

ProductLife Group strengthens global drug development capabilities with acquisition of IntiQuan

ProductLife Group (PLG), a regulatory, scientific, compliance, and digital transformation consulting services firm for the life sciences industry, has acquired IntiQuan, a Swiss boutique...

Approvals

Roche’s Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness

The European Medicines Agency has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’...

Santhera secures approval from China’s NMPA for AGAMREE to treat Duchenne muscular dystrophy

China’s National Medical Products Administration (NMPA) has approved Santhera Pharmaceuticals' AGAMREE (vamorolone) for use in China in patients with Duchenne muscular dystrophy (DMD) aged...

Imfinzi approved in US for patients with limited-stage small cell lung cancer

Novartis’ Kisqali receives European Commission approval in early breast cancer

European Commission approves BeiGene’s TEVIMBRA for first-line treatment of advanced/metastatic esophageal squamous cell carcinoma and gastric or gastroesophageal junction cancer

U.S. FDA approves Shorla Oncology’s IMKELDI oral solution for certain forms of leukemia and other cancers

Manufacturiung

MANUFACTURING

$3bn expansion for Lilly’s recently acquired manufacturing facility in Wisconsin

Eli Lilly and Company has announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing facility that the company acquired earlier this year. This investment...

Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop digital twin of CAR-T manufacturing

Process filter maker creates new global pharma and healthcare role

GSK to make up to $800m manufacturing investment in Pennsylvania

FibroBiologics and Charles River collaborate to manufacture fibroblast cell-based therapies for chronic diseases

£4.5m project launched to tackle acute skills shortage in UK medicines manufacturing

Finance

AbbVie to strengthen immunology pipeline with acquisition of Nimble Therapeutics

ProQR Therapeutics secures $8.1m from Rett Syndrome Research Trust to expand RNA editing collaboration

CBC Group completes acquisition of UCB’s mature neurology and allergy business in China

Roche to acquire Poseida Therapeutics

Research & Development
Latest

R&D

Orion and Abilita Therapeutics to develop innovative antibody therapeutics

20th December 2024

Orion Corporation and Abilita Therapeutics have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas...

R&D

Conduit Pharmaceuticals partners with Sarborg to leverage AI and cybernetics to optimize drug development

16th December 2024

Conduit Pharmaceuticals has entered into an agreement with Sarborg to leverage an advanced artificial intelligence (AI) and cybernetics platform to evaluate key deliverables across...

R&D

Datopotamab deruxtecan granted Breakthrough Therapy Designation in U.S. for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

13th December 2024

Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of adult patients with locally advanced or metastatic...

R&D

Tolebrutinib designated Breakthrough Therapy by FDA for non-relapsing secondary progressive multiple sclerosis

13th December 2024

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple...

R&D

Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US

12th December 2024

The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in...